Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease by Eddowes, P. J., McDonald, N., Davies, N., Semple, S. I. K., Kendall, T. J., Hodson, J., Newsome, P. N., Flintham, R. B., Wesolowski, R., Blake, L., Duarte, R. V., Kelly, C. J., Herlihy, A. H., Kelly, M. D., Olliff, S. P., Hübscher, S. G., Fallowfield, J. A., Hirschfield, G. M.

Get full text

Correlation of Non-Invasive Markers of Liver Fibrosis in Patients with Primary Sclerosing Cholangitis: A Validation Cohort by Eddowes, P, Trivedi, P, Corrigan, M, Ferguson, J, Hirschfield, G

Get full text

Blockade of OX40-OX40L prevents the development of hepatic autoimmunity in a regulatory T cell deficient model by Webb, G.J, Gaspal, F, Eddowes, P, Reynolds, G, Hirschfield, G.M, Lane, P

Get full text

Non-invasive multiparametric MRI (LiverMultiScanTM) effectively excludes NASH and liver fibrosis in at risk patients by Wilman, H.R, Kelly, M, McDonald, N, Eddowes, P, Pavlides, M, Neubauer, S, Fallowfield, J, Hirschfield, G, Banerjee, R

Get full text

Follow‐up magnetic resonance imaging/3D‐magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret by Zenouzi, R., Liwinski, T., Yamamura, J., Weiler‐Normann, C., Sebode, M., Keller, S., Lohse, A. W., Schramm, C., Aabakken, L., Arrivé, L., Bowlus, C.L., Bungay, H., Buuren, H.R., Cardinale, V., Carey, E.J., Chazouillères, O., Cheung, A., Culver, E.L., Dufour, J.F., Dumonceau, J.M., Eaton, J.E., Eddowes, P.J., Färkkilä, M., Floreani, A., Franceschet, I., Hohenester, S.D., Kemmerich, G., Krawczyk, M., Zimmer, V., Lenzen, H., Levy, C., Marschall, H.U., Marzioni, M., Motta, R., Muratori, L., Pereira, S.P., Poley, J.W., Rimola, J., Ringe, K.I., Rushbrook, S., Simpson, B.W., Schrumpf, E., Spina, J.C., Terziroli Beretta‐Piccoli, B., Trauner, M., Tringali, A., Venkatesh, S.K., Vesterhus, M., Villamil, A., Weismüller, T.J., Ytting, H.

Get full text

SAT-367 - Correlation of Non-Invasive Markers of Liver Fibrosis in Patients with Primary Sclerosing Cholangitis: A Validation Cohort by Eddowes, P., Trivedi, P., Corrigan, M., Ferguson, J., Hirschfield, G.

Get full text

Algorithm to identify patients with an activity grade > 2 in type 2 diabetic patients with non-alcoholic fatty liver disease (NAFLD)-development in a large prospective multicenter... by Eddowes, P., Allison, M., Tsochatzis, E., Anstee, Q., Sheridan, D., Guha, I.N., Cobbold, J., Paradis, Valérie, Bedossa, P., Newsome, P.

Get full text

FRI-424 - Algorithm to identify patients with an activity grade > 2 in type 2 diabetic patients with non-alcoholic fatty liver disease (NAFLD)-development in a large prospective mu... by Eddowes, P., Allison, M., Tsochatzis, E., Anstee, Q., Sheridan, D., Guha, I.N., Cobbold, J., Paradis, Valérie, Bedossa, P., Newsome, P.

Get full text

PS-180 - Performance of controlled attenuation parameter (CAP) to assess steatosis in a large prospective multicentre UK study of patients with non-alcoholic fatty liver disease (N... by Eddowes, P., Allison, M., Tsochatzis, E., Anstee, Q., Sheridan, D., Guha, I.N., Cobbold, J., Paradis, V., Bedossa, P., Newsome, P.

Get full text

Performance of controlled attenuation parameter (CAP) to assess steatosis in a large prospective multicentre UK study of patients with non-alcoholic fatty liver disease (NAFLD) by Eddowes, P., Allison, M., Tsochatzis, E., Anstee, Q., Sheridan, D., Guha, I.N., Cobbold, J., Paradis, V., Bedossa, P., Newsome, P.

Get full text

PS-133 - Blockade of OX40-OX40L prevents the development of hepatic autoimmunity in a regulatory T cell deficient model by Webb, G.J., Gaspal, F., Eddowes, P., Reynolds, G., Hirschfield, G.M., Lane, P.

Get full text

Evolving diagnostic pathways in liver disease: using quantitative magnetic resonance imaging to distinguish parenchymal and biliary disease by Arndtz, K., Irving, B., Brady, S.M., Jayaratne, N., Eddowes, P., Kelly, M., Green, D., Banerjee, R., Neubauer, S., Hirschfield, G.

Get full text

SAT-091 - Evolving diagnostic pathways in liver disease: using quantitative magnetic resonance imaging to distinguish parenchymal and biliary disease by Arndtz, K., Irving, B., Brady, S.M., Jayaratne, N., Eddowes, P., Kelly, M., Green, D., Banerjee, R., Neubauer, S., Hirschfield, G.

Get full text

Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease and type 2 diabetes by Pennisi, G., Enea, M., Falco, V., Aithal, G.P., Palaniyappan, N., Yilmaz, Y., Boursier, J., Cassinotto, C., de Lédinghen, V., Chan, W.K., Mahadeva, S., Eddowes, P., Newsome, P., Karlas, T., Wiegand, J., Wong, V. Wai-Sun, Schattenberg, J.M., Labenz, C., Kim, W., Lee, M.S., Lupsor-Platon, M., Cobbold, J.F.L., Fan, J., Shen, F., Staufer, K., Trauner, M., Stauber, R., Nakajima, A., Yoneda, M., Bugianesi, E., Younes, R., Gaia, S., Zheng, M., Cammà, C., Anstee, Q.M., Mózes, F.E., Pavlides, M., Petta, S.

Get full text

THU-498 - Non-invasive multiparametric MRI (LiverMultiScanTM) effectively excludes NASH and liver fibrosis in at risk patients by Wilman, H.R., Kelly, M., McDonald, N., Eddowes, P., Pavlides, M., Neubauer, S., Fallowfield, J., Hirschfield, G., Banerjee, R.

Get full text

Pancreatic enzyme replacement therapy in patients with pancreatic cancer: A national prospective study by Haldar, D., McKay, S.C., Pande, R., Patel, R., Pericleous, S., Rinkoff, S., Ghazanfar, M., Saji, S., Sheikh, S., Malik, H., Darley, E., Smyth, R., King, A., Burahee, A., Devogel, C., Murray, E., Young, R., Portal, J., Abeysekera, K.W.M., Maccabe, T., Anderson, J., Sheiybani, G., Khan, A., Kirk, S., Silva, M., Eardley, N., Wadsworth, P., Bell, C., Tay, Y., Adnan, M., Rekhraj, S., Nelapatia, R., Verebcean, M., Apollos, J., Shahdoost, A., French, J.J., Sen, G., Thakkar, R., Kanwar, A., Rodham, P., Joseph, M., Cooper, J., Noor, R., Kanakala, V., Jones, R., Gomez, M., Whitehead-Clarke, T., Whitelaw, D., Waters, J., Mealey, L., Merh, R., Ingram, S., Bhamra, N., Resool, S., Wothers, T., Shingler, G., Dykes, K., Wilkinson, B., Baker, S., Hall, M., Finch, J.G., Gupta, A., Baxter, A., Holt, A., Pillai, M., Glen, P., Drozdzik, S., Kourounis, G., Thomas, I., Subar, D., Prasad, S., Yoong, A., Fusai, G., Lee, E., McNally, E., Sherif, A.E., Dickerson, L.D., Alame, R., Bull, C., Hebbar, S., Kamran, U., Fisher, N., Iyer, S., McMurtry, H., Richards, E., Palaniyappan, N., Suhool, A., Osborne, A., Thomas-Jones, I., Valverde, J., Barker, S., Wan, A., Smith, A., Potts, J., Disney, B., Obisesan, A., Webb, K., Somasundaram, M., Jamieson, W., Tahir, I.

Get full text

Techniques for assessing the protective properties of chromated conversion coatings—Part II: Galvanized steel by Gilroy, D., Eddowes, P.J., Dalrymple, I.M., Madina, V., Seco, F., del Barrio, A., Parkes, J., Byrne, M., Byrne, R., Almeida, E.M., Maia, A., Pereira, D., Bentes, F.L.

Get full text

Techniques for assessing the protective properties of chromated conversion coatings—Part I: Aluminum by Gilroy, D., Eddowes, P.J., Dalrymple, I.M., Azkarate, I., Madina, V., Seco, F., del Barrio, A., Parkes, J., Byrne, M., Byrne, R., Almeida, E.M., Maia, A., Pereira, D., Bentes, F.L.

Get full text

Techniques for assessing the protective properties of chromated conversion coatings. II. Galvanized steel by Gilroy, D, Eddowes, P J, Dalrymple, I M, Madina, V, Seco, F, del Barrio, A, Parkes, J, Byrne, M, Byrne, R, Almeida, E M, Maia, A, Pereira, D, Bentes, F L

Get full text

Techniques for assessing the protective properties of chromated conversion coatings. I. Aluminum by Gilrov, D, Eddowes, P J, Dalrymple, I M, Azkarate, I, Madina, V, Seco, F, del Barrio, A, Parkes, J, Byrne, M, Byrne, R, Almeida, E M, Maia, A, Pereira, D, Bentes, F L

Get full text